Abiopharma

🔍 Turner Andrea (Director)

Company: Honest Company, Inc. (HNST)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 34,396 shares of Common Stock at $5.3 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 282,304.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 29,899 shares of Common Stock at $5.21 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 252,405.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.46, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F2: Includes 92,936 restricted stock units which are payable in an equivalent number of shares of the Issuer's common stock.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.25, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.